This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hypergammalglobulinemia, unspecified
D3_HYPERGAMMAGLONAS
immune system disease: A disorder resulting from an abnormality in the immune system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
35 |
4. Check minimum number of eventsNone |
35 |
5. Include endpointsNone |
35 |
6. Filter based on genotype QC (FinnGen only) |
35 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D89
- Name in latin
- Hypergammaglobulinaemia non specificata
Similar endpoints
↥List of similar endpoints to
Hypergammalglobulinemia, unspecified
based on the number of shared cases.
Similar with more cases:
- Other disorders involving the immune mechanism, not elsewhere classified
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 225 | 103 | 120 |
| Only index persons | 169 | 84 | 85 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 66.41 | 65.47 | 67.14 |
| Only index persons | 64.83 | 64.44 | 65.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 35 | 15 | 20 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 60.02 | 51.45 | 66.45 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020630) Protein [Mass/volume] in Serum or Plasma
11
19
7.98
6.56
4.6
1.7
g/l
74.2
67.9
1.00
11
14
(40768446) Kidney Pathology biopsy report
6
0
+∞
6.43
1.8
0.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
16
8.35
6.34
4.6
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
0
+∞
5.33
2.6
0.0
ml
1890.0
—
—
5
0
(42870588) Differential panel, method unspecified - Blood
19
84
3.76
3.60
10.3
5.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
23
116
3.87
3.57
16.0
5.6
mmol/l
1.2
1.2
0.01
17
98
(3022096) Basophils/100 leukocytes in Blood
22
113
3.55
3.22
11.0
6.0
%
0.6
0.7
0.18
22
108
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
5
11.34
3.07
2.8
1.2
g/l
0.2
0.2
—
5
5
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
5
11.34
3.07
2.8
1.4
g/l
1.3
0.9
—
5
5
(3002030) Lymphocytes/100 leukocytes in Blood
22
116
3.41
3.03
11.2
6.4
%
28.5
26.6
0.34
22
111
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
9
7.76
2.99
1.5
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
16
70
3.37
2.97
14.1
3.3
ph
7.4
7.4
—
6
15
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
6
9.44
2.84
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
7
8.08
2.63
5.8
1.7
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
7
8.08
2.63
5.8
2.0
kpa
4.6
5.3
—
5
7
(3027315) Oxygen [Partial pressure] in Blood
5
7
8.08
2.63
5.8
2.0
kpa
9.1
7.2
—
5
7
(40768443) Skin Pathology biopsy report
5
8
7.05
2.45
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
9
6.26
2.29
7.6
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
10
5.62
2.14
3.0
5.5
mmol/l
23.9
24.6
—
5
10
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
27
3.53
2.09
2.0
1.9
—
—
—
0
0
(4035726)
7
24
3.38
1.83
2.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
31
3.04
1.79
2.3
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
13
4.29
1.78
8.6
2.2
kpa
4.8
4.7
—
5
13
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
5
13
4.29
1.78
8.2
2.0
mmol/l
-2.3
0.6
—
5
7
(3007853) Bacteria identified in Skin by Aerobe culture
7
25
3.24
1.75
2.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
6
20
3.40
1.66
9.5
5.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
33
2.84
1.66
2.9
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
21
3.23
1.58
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
40
2.67
1.54
2.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17
103
2.26
1.49
5.2
2.1
ug/l
155.6
84.1
1.03
17
95
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
16
3.46
1.49
1.8
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
16
3.46
1.49
1.4
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
55
2.46
1.46
10.3
4.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
23
2.93
1.43
2.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
17
3.25
1.41
1.8
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
26
197
2.24
1.32
7.5
3.9
mm/h
31.3
10.7
2.25
26
174
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
40
2.29
1.21
3.6
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
8
41
2.23
1.18
9.6
1.6
umol/l
13.5
14.5
—
8
36
(3037522) Nuclear Ab [Titer] in Serum
7
32
2.48
1.16
1.9
1.4
—
297.1
—
0
7
(3023368) Bacteria identified in Blood by Culture
12
69
2.12
1.14
8.8
3.7
—
—
—
0
0
(3012544) pH of Venous blood
5
21
2.60
1.13
5.8
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
49
2.12
1.09
3.7
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
35
2.24
1.07
4.6
1.3
—
—
—
0
0
(3015736) pH of Urine
16
105
1.96
1.07
5.6
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
16
106
1.94
1.03
12.8
7.7
inr
1.3
1.1
—
5
38
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
13
80
1.99
1.03
1.7
3.2
ng/l
1150.8
976.8
0.09
13
60
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
28
2.37
0.97
3.3
3.8
u/l
27.8
26.5
—
6
21
(3013512) EKG study
12
75
1.91
0.89
3.5
4.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
24
188
1.88
0.88
5.5
4.5
pmol/l
14.9
15.1
0.15
24
166
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
15
102
1.82
0.87
4.1
2.2
nmol/l
67.3
71.9
0.39
15
85
(36304419) Bacteria [Presence] in Urine
12
76
1.88
0.86
9.9
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
25
2.16
0.76
19.4
3.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
19
143
1.72
0.76
10.4
6.7
umol/l
9.1
11.4
1.50
19
137
(3019832) Treponema pallidum Ab [Presence] in Serum
5
26
2.07
0.74
3.0
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
12
83
1.68
0.62
4.7
2.5
u/l
112.6
51.4
0.49
12
78
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
23
0.00
0.60
0.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9
129
0.59
0.57
4.2
3.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11
76
1.65
0.57
4.2
3.9
u/l
27.0
37.7
0.68
11
70
(40768797) Stomach Pathology biopsy report
6
40
1.60
0.54
1.0
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
68
1.66
0.54
7.1
4.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
27
239
1.57
0.47
6.1
4.9
mu/l
2.6
2.0
0.96
27
212
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
58
1.49
0.46
8.8
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
10
71
1.57
0.45
2.3
1.4
nmol/l
19.5
18.6
—
10
58
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
14
111
1.44
0.38
2.6
1.8
pmol/l
80.5
93.2
—
8
59
(1761868) Lipid panel - Serum or Plasma
8
105
0.69
0.36
3.4
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
103
1.42
0.35
11.8
2.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
8
65
1.30
0.30
1.6
1.7
mmol/l
1.3
1.4
—
8
53
(3026008) Bacteria identified in Urine by Culture
9
73
1.31
0.29
3.6
3.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
20
223
0.76
0.25
26.1
17.3
g/l
331.9
332.5
0.12
20
223
(3037467) Urinalysis macro (dipstick) panel - Urine
20
177
1.30
0.24
10.8
4.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
18
158
1.29
0.23
4.1
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
15
129
1.28
0.22
10.3
3.6
estimate
0.0
0.0
—
5
26
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
11
0.00
0.22
0.0
2.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
76
0.75
0.18
13.7
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
107
0.79
0.16
11.6
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
22
236
0.82
0.14
20.2
15.0
%
38.5
40.4
0.78
15
170
(3044889) 12 lead EKG panel
20
187
1.16
0.09
5.5
3.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
19
177
1.16
0.09
8.0
4.0
—
26.2
—
0
5
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
19
177
1.16
0.09
5.8
3.2
u/l
49.8
63.5
0.52
19
169
(3000963) Hemoglobin [Mass/volume] in Blood
29
294
0.92
0.09
41.6
19.9
g/l
127.7
135.8
2.19
29
289
(3035941) MCH [Entitic mass]
29
294
0.92
0.09
40.9
19.6
pg
31.0
30.4
0.77
29
289
(3024731) MCV [Entitic volume]
29
294
0.92
0.09
41.1
19.7
fl
93.2
91.1
1.12
29
289
(3010813) Leukocytes [#/volume] in Blood
29
294
0.92
0.09
41.4
19.7
e9/l
6.9
6.5
0.51
29
287
(3026361) Erythrocytes [#/volume] in Blood
29
294
0.92
0.09
41.2
19.7
e12/l
4.2
4.5
3.01
29
286
(3007461) Platelets [#/volume] in Blood
29
293
0.94
0.09
41.4
19.8
e9/l
250.2
247.1
0.07
29
287
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
29
280
1.21
0.08
21.4
10.8
u/l
21.8
26.3
1.70
29
273
(40761511) CBC panel - Blood by Automated count
27
277
0.89
0.08
27.3
12.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
7
82
0.82
0.08
3.6
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
23
219
1.15
0.07
31.7
16.2
%
13.6
13.6
0.05
23
214
(40768804) Tissue Pathology biopsy report
11
105
1.07
0.00
3.0
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
24
245
0.94
0.00
9.2
6.1
mmol/mol
41.5
40.0
0.30
24
226
(3009261) Glucose [Presence] in Urine by Test strip
13
132
0.98
0.00
11.8
3.6
estimate
0.0
0.0
—
5
25
(3021601) Nitrite [Presence] in Urine by Test strip
13
129
1.01
0.00
14.8
4.8
estimate
0.0
0.0
—
5
26
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
5.0
—
4.1
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
6.0
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.4
—
19.6
—
0
5
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
5.0
—
105.8
—
0
5
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.4
—
100.4
—
0
5
(3035637) Corticotropin [Mass/volume] in Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
28
272
1.15
0.00
32.1
14.7
mmol/l
4.0
4.0
0.28
28
267
(3003694) ABO and Rh group [Type] in Blood
6
65
0.91
0.00
2.2
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
228.0
—
0
6
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
5.5
—
1.4
—
0
6
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6
59
1.02
0.00
3.8
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
6
62
0.96
0.00
4.3
3.0
—
1.0
—
0
11
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
5.5
—
9.5
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
29
282
1.17
0.00
35.9
15.6
umol/l
113.8
78.5
1.48
29
282
Mortality – FinRegistry
↥Association
Association between endpoint D3_HYPERGAMMAGLONAS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_HYPERGAMMAGLONAS | 2.562 [1.51, 4.34] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 57 out of 109 males with D3_HYPERGAMMAGLONAS died.
Mortality risk
Mortality risk for people of age
years, who have D3_HYPERGAMMAGLONAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.467% |
| 5 | No data | 2.937% |
| 10 | No data | 7.793% |
| 15 | No data | 14.578% |
| 20 | No data | 23.334% |
Relationships between endpoints
↥Index endpoint: D3_HYPERGAMMAGLONAS – Hypergammalglobulinemia, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data